Literature DB >> 12077213

Phosphodiesterase 1B knock-out mice exhibit exaggerated locomotor hyperactivity and DARPP-32 phosphorylation in response to dopamine agonists and display impaired spatial learning.

Tracy M Reed1, David R Repaske, Gretchen L Snyder, Paul Greengard, Charles V Vorhees.   

Abstract

Using homologous recombination, we generated mice lacking phosphodiesterase-mediated (PDE1B) cyclic nucleotide-hydrolyzing activity. PDE1B(-/-) mice showed exaggerated hyperactivity after acute D-methamphetamine administration. Striatal slices from PDE1B(-/-) mice exhibited increased levels of phospho-Thr34 DARPP-32 and phospho-Ser845 GluR1 after dopamine D1 receptor agonist or forskolin stimulation. PDE1B(-/-) and PDE1B(+/-) mice demonstrated Morris maze spatial-learning deficits. These results indicate that enhancement of cyclic nucleotide signaling by inactivation of PDE1B-mediated cyclic nucleotide hydrolysis plays a significant role in dopaminergic function through the DARPP-32 and related transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077213      PMCID: PMC6757711     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  72 in total

Review 1.  The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions.

Authors:  M D Houslay; M Sullivan; G B Bolger
Journal:  Adv Pharmacol       Date:  1998

2.  Brain distribution of four rat homologues of the Drosophila dunce cAMP phosphodiesterase.

Authors:  P Engels; S Abdel'Al; P Hulley; H Lübbert
Journal:  J Neurosci Res       Date:  1995-06-01       Impact factor: 4.164

3.  Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species.

Authors:  R R Holson; B Pearce
Journal:  Neurotoxicol Teratol       Date:  1992 May-Jun       Impact factor: 3.763

4.  Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase.

Authors:  R K Sharma; J H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Neuronal and behavioural abnormalities in striatal function in DARPP-32-mutant mice.

Authors:  N Hiroi; A A Fienberg; C N Haile; M Alburges; G R Hanson; P Greengard; E J Nestler
Journal:  Eur J Neurosci       Date:  1999-03       Impact factor: 3.386

6.  Amphetamine regulates gene expression in rat striatum via transcription factor CREB.

Authors:  C Konradi; R L Cole; S Heckers; S E Hyman
Journal:  J Neurosci       Date:  1994-09       Impact factor: 6.167

7.  Calmodulin and Ca2+-dependent phosphorylation and dephosphorylation of 63-kDa subunit-containing bovine brain calmodulin-stimulated cyclic nucleotide phosphodiesterase isozyme.

Authors:  R K Sharma; J H Wang
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

8.  The cyclic AMP system and Drosophila learning.

Authors:  R L Davis; J Cherry; B Dauwalder; P L Han; E Skoulakis
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

9.  Calcium/calmodulin-activated phosphodiesterase expressed in olfactory receptor neurons.

Authors:  F F Borisy; G V Ronnett; A M Cunningham; D Juilfs; J Beavo; S H Snyder
Journal:  J Neurosci       Date:  1992-03       Impact factor: 6.167

10.  Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency.

Authors:  M E Bach; R D Hawkins; M Osman; E R Kandel; M Mayford
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

View more
  30 in total

Review 1.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 2.  Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface.

Authors:  John L Waddington; Colm O'Tuathaigh; Gerard O'Sullivan; Katsunori Tomiyama; Noriaki Koshikawa; David T Croke
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase.

Authors:  Z Xie; W O Adamowicz; W D Eldred; A B Jakowski; R J Kleiman; D G Morton; D T Stephenson; C A Strick; R D Williams; F S Menniti
Journal:  Neuroscience       Date:  2006-02-17       Impact factor: 3.590

Review 4.  Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease?

Authors:  Dominic Ngima Nthenge-Ngumbau; Kochupurackal P Mohanakumar
Journal:  Mol Neurobiol       Date:  2017-01-06       Impact factor: 5.590

Review 5.  Phosphodiesterases and adrenal Cushing in mice and humans.

Authors:  E Szarek; C A Stratakis
Journal:  Horm Metab Res       Date:  2014-09-18       Impact factor: 2.936

6.  Phosphodiesterase-1b deletion confers depression-like behavioral resistance separate from stress-related effects in mice.

Authors:  J R Hufgard; M T Williams; C V Vorhees
Journal:  Genes Brain Behav       Date:  2017-06-07       Impact factor: 3.449

Review 7.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

8.  Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.

Authors:  Akinori Nishi; Mahomi Kuroiwa; Diane B Miller; James P O'Callaghan; Helen S Bateup; Takahide Shuto; Naoki Sotogaku; Takaichi Fukuda; Nathaniel Heintz; Paul Greengard; Gretchen L Snyder
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

Review 9.  Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.

Authors:  F Ahmad; T Murata; K Shimizu; E Degerman; D Maurice; V Manganiello
Journal:  Oral Dis       Date:  2014-09-12       Impact factor: 3.511

10.  Prediction and validation of a mechanism to control the threshold for inhibitory synaptic plasticity.

Authors:  Yuichi Kitagawa; Tomoo Hirano; Shin-ya Kawaguchi
Journal:  Mol Syst Biol       Date:  2009-06-16       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.